BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34168648)

  • 21. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
    Tweya H; Feldacker C; Phiri S; Ben-Smith A; Fenner L; Jahn A; Kalulu M; Weigel R; Kamba C; Banda R; Egger M; Keiser O
    PLoS One; 2013; 8(2):e56248. PubMed ID: 23457534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
    Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.
    Gersh JK; Barnabas RV; Matemo D; Kinuthia J; Feldman Z; Lacourse SM; Mecha J; Warr AJ; Kamene M; Horne DJ
    BMC Infect Dis; 2021 Feb; 21(1):218. PubMed ID: 33632173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
    Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
    Front Immunol; 2021; 12():648216. PubMed ID: 33828558
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis.
    Nalukwago S; Lancioni CL; Oketcho JB; Canaday DHE; Boom WH; Ojok L; Mayanja-Kizza H
    Afr Health Sci; 2017 Dec; 17(4):954-962. PubMed ID: 29937865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Diagnosis of TB in the HIV Positive Population.
    Vittor AY; Garland JM; Gilman RH
    Ann Glob Health; 2014; 80(6):476-85. PubMed ID: 25960097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
    Ngongondo M; Miyahara S; Hughes MD; Sun X; Bisson GP; Gupta A; Kumwenda J; Lavenberg JA; Torres TS; Nyirenda M; Kidonge KK; Hosseinipour MC;
    J Acquir Immune Defic Syndr; 2018 May; 78(1):54-61. PubMed ID: 29406428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.
    Zhang X; Guo J; Fan S; Li Y; Wei L; Yang X; Jiang T; Chen Z; Wang C; Liu J; Ping Z; Xu D; Wang J; Li Z; Qiu Y; Li JC
    PLoS One; 2013; 8(12):e81076. PubMed ID: 24349033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
    Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
    Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
    Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
    Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
    Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
    PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TB or not TB in HIV infection.
    Costache DV; Isac I; Mihăescu T; Manciuc C
    Pneumologia; 2016; 65(4):210-1. PubMed ID: 29542904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.